Last reviewed · How we verify
Metoprolol Tartrate Tablets 25 mg
Metoprolol Tartrate Tablets 25 mg is a Small molecule drug developed by Mylan Pharmaceuticals Inc. It is currently in Phase 1 development.
At a glance
| Generic name | Metoprolol Tartrate Tablets 25 mg |
|---|---|
| Sponsor | Mylan Pharmaceuticals Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Palpitations
- Decreased appetite
- Medical device site reaction
- nausea
- Constipation
- Dizziness
- Sleep problems
- Dizziness postural
- Tension
- Arthropod bite
- Near Syncopal Event
Key clinical trials
- Interstitial Cystitis: Examination of the Central Autonomic Network (PHASE4)
- Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects (PHASE4)
- Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg (PHASE1)
- A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate (PHASE1)
- Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale (PHASE4)
- S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients. (PHASE4)
- Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex. (PHASE4)
- Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Metoprolol Tartrate Tablets 25 mg CI brief — competitive landscape report
- Metoprolol Tartrate Tablets 25 mg updates RSS · CI watch RSS
- Mylan Pharmaceuticals Inc portfolio CI
Frequently asked questions about Metoprolol Tartrate Tablets 25 mg
What is Metoprolol Tartrate Tablets 25 mg?
Metoprolol Tartrate Tablets 25 mg is a Small molecule drug developed by Mylan Pharmaceuticals Inc.
Who makes Metoprolol Tartrate Tablets 25 mg?
Metoprolol Tartrate Tablets 25 mg is developed by Mylan Pharmaceuticals Inc (see full Mylan Pharmaceuticals Inc pipeline at /company/mylan-pharmaceuticals-inc).
What development phase is Metoprolol Tartrate Tablets 25 mg in?
Metoprolol Tartrate Tablets 25 mg is in Phase 1.
What are the side effects of Metoprolol Tartrate Tablets 25 mg?
Common side effects of Metoprolol Tartrate Tablets 25 mg include Headache, Palpitations, Decreased appetite, Medical device site reaction, nausea, Constipation.